Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
Clinical trial NCT00952484 · COMPLETED
Trial details
- NCT number
- NCT00952484
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-07-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.